Literaturverzeichnis (Oberarzt Dr. med. Daniel Oruzio)

Literaturverzeichnis (Oberarzt Dr. med. Daniel Oruzio)
1. Oruzio D, Hempel D, Schlimok G:
Knochenmarkmikrometastasen epithelialer Tumoren. Nachweis und klinische
Bedeutung.
Der Onkologe (1997) 3:66-72
2. Müller P, Hempel D, Oruzio D, Ehnle S, Kolloch K, Schlimok G:
Sequential immunotyping and genotyping of tumor cells in bone marrow of
cancer patients: a model study.
Cytometry (1998) 33:492-7
3. Hempel P, Müller P, Oruzio D, Behr W, Brockmeyer C, Wochner M, Ehnle S,
Riethmüller R, Schlimok G:
Combination of high-dose chemotherapy and monoclonal antibody in breastcancer patients: a pilot trial to monitor treatment effects on disseminated tumor
cells.
Cytotherapy (2000) 2:287-95
4. Oruzio D, Aulmann C, Eller N, Stranner S, Waxenecker G, Schreiber O,
Obwaller O, Mudde GC, Schlimok G:
Results from a phase I clinical trial with IGN3111, a fully humanized IgG1
antibody against Lewis Y in patients with solid tumors expressing Lewis Y
antigen.
Journal of Clinical Oncology, Proceedings of ASCO 2004 (Post-Meeting
Edition), Vol. 22, No. 14S (July 15 Supplement), 2004:2624
5. Oruzio D, Hempel D, Finkl M, Ehnle S, Steinfeld D, Wischnik A, Witte J,
Schlimok G:
Enrichment of disseminated tumor cells (DTC) in bone marrow (BM) from
patients with breast cancer (BC) using a magnetic cell sorting device (MCSD)Method and prognostic significance.
Journal of Clinical Oncology, 2005 ASCO Annual Meeting Proceedings, Vol. 23,
No. 16S, Part I of II (June 1 Supplement), 2005:9640
6. Hentrich M, Oruzio D, Jäger G, Schlemmer M, Schleuning M, Schiel X,
Hiddemann W, Kolb HJ:
Impact of human herpesvirus-6 after haematopoietic stem cell transplantation.
Br J Haematol (2005) 128:66-72
7. Braun S, Vogl FD, Naume B, Janni W, Osborne MP, Coombes RC, Schlimok G,
Diel IJ, Gerber B, Gebauer G, Pierga JY, Marth C, Oruzio D, Wiedswang G,
Solomayer EF, Kundt G, Strobl B, Fehm T, Wong GY, Bliss J, Vincent-Salomon
A, Pantel K:
A pooled analysis of bone marrow micrometastasis in breast cancer.
N Engl J Med (2005) 353:793-802
8. Heinemann V, Fischer Von Weikersthal L, Moosmann N, Vehling-Kaiser U,
Stauch M, Oruzio D, Schulze M, Walther J, Weiss J, Dietzfelbinger H:
Cetuximab + capecitabine + irinotecan (CCI) versus cetuximab + capecitabine +
oxaliplatin (CCO) as first line therapy for patients with metastatic colorectal
cancer (CRC): Preliminary results of a randomized phase II trial of the AIO CRC
Study Group.
Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I,
Vol. 24, No. 18S (June 20 Supplement), 2006:3550
9. Aulmann C, Seufert P, Sandherr M, Schlimok G, Schulze R, Oruzio D:
A 65-year-old female patient with breast cancer accompanied by
thrombocytopenia and hyperfibrinolysis.
Internist (Berl) (2007) 48:1015-9 (German)
10. Schmid C, Schleuning M, Hentrich M, Markl GE, Gerbitz A, Tischer J,
Ledderose G, Oruzio D, Hiddemann W, Kolb HJ:
High antileukemic efficacy of an intermediate intensity conditioning regimen for
allogeneic stem cell transplantation in patients with high-risk acute myeloid
leukemia in first complete remission.
Bone Marrow Transplant (2008) 41:721-7
11. Märkl B, Kerwel TG, Jähnig HG, Oruzio D, Arnholdt HM, Schöler C, Anthuber
M, Spatz H:
Methylene blue-assisted lymph node dissection in colon specimens: a
prospective, randomized study.
Am J Clin Pathol (2008) 130:913-9
12. Braess J, Spiekermann K, Staib P, Gruneisen A, Wormann B, Ludwig WD,
Serve H, Reichle A, Peceny R, Oruzio D, Schmid C, Schiel X, Hentrich M,
Sauerland C, Unterhalt M, Fiegl M, Kern W, Buske C, Bohlander S, Heinecke A,
Baurmann H, Beelen DW, Berdel WE, Buchner T, Hiddemann W:
Dose-dense induction with sequential-high-dose cytarabine and mitoxantone
(S-HAM) and pegfilgrastim results in a high efficacy and a short duration of
critical neutropenia in de-novo acute myeloid leukemia - a pilot study of the
AML-CG.
Blood (2009) (Epub ahead of print)